Chapter 3 Market and Technology Background
- Cancer
- Recent Advances in Technology
- Invasive Power
- Circulating Tumor Cells
- Phenotypic Characteristics
- CTC Clusters
- CTC Detection
- Cancer Stem Cells (Cscs)
- Circulating Tumor Cells - Potential Uses
- Proliferative Activity
- Epithelial Marker Genes on Circulating Tumor Cells
- Circulating Tumor Cells and Stem Cell-Like Phenotype
- CTCs and Primary Tumor Cells: a Comparison
- Metastasis
- Future Directions
- Metastatic Development in Cancer Patients
- Circulating Tumor Cell Migration
- Circulating Tumor Cell Detection
- Methods
- Cellsearch Method
- Epic Sciences Method
- Maintrac
- Iset Test
- Challenges for Detection
- Clinical Application of Circulating Tumor Dna
- Circulating Tumor Cells as Predictor of Response to Therapy
- Measurement of CTCs - Applications
- Conclusion
Chapter 4 CTC Diagnostic Technologies
- Finding Circulating Tumor Cells
- Why CTCs?
- Current CTC Detection and Isolation Methods
- New Technologies for Detection
- Cancer Prognosis
- Nucleic Acid-Based Methods
- Clinical Testing
- Summary
- New Emerging Technologies
Chapter 5 Impact of Covid-19 on the CTC Diagnostics Market
- Overview
- Covid-19 and Cancer Screening
- Impact of Covid-19 on Company Revenues
Chapter 6 Market Dynamics
- Market Drivers
- Rising Incidence of Cancer Worldwide
- Advantages Offered, by Noninvasivene Approach, by Circulating Tumor Cells
- Advancements in Ngs and Immunofluorescence Technologies
- Growing Awareness About the Novel Diagnostic Methods for Cancers
- Market Restraints
- High Costs of CTC Diagnostics
- Rarity of CTCs in Blood Samples and Lack of Skilled Professionals for CTC Diagnostics
- Market Opportunities
- Circulating Tumor Cells as a Therapeutic Target
- Competitive Landscape
Chapter 7 Market Breakdown by Cancer Type
- Global Market for CTC Diagnostics by Cancer Type
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
Chapter 8 Market Breakdown by Technology
- Global Market for CTC Diagnostics by Technology
- CTC Enrichment and Detection
- CTC Direct Detection
- CTC Analysis
Chapter 9 Market Breakdown by Application
- Global Market for CTC Diagnostics by Application
- Clinical/Liquid Biopsy
- Research
Chapter 10 Market Breakdown by Region
- Global Market for CTC Diagnostics by Region
- North America
- Europe
- Asia-Pacific
- Rest of World
Chapter 11 Company Profiles
- Bio-Techne Corp. (Advanced Cell Diagnostics Inc.)
- Biocept, Inc.
- Biofluidica
- Creatv Microtech Inc.
- Fluxion Biosciences, Inc.
- Greiner Bio-One International GmbH
- Ikonisys, Inc.
- Ivdiagnostics, Inc.
- Menarini Silicon Biosystems (Formerly Veridex LLC)
- Miltenyi Biotec
- Precision Medicine Group LLC
- Qiagen N.V.
- Rarecells, Inc.
- Screencell
- Stemcell Technologies Inc.
List of Tables
Table A : New Additions to the Updated Version of the Report
Summary Table : Global Market for Circulating Tumor Cells (CTC) Diagnostics, by Cancer Type, Through 2026
Table 1 : Categories of Stem Cells
Table 2 : Product Categories
Table 3 : Key Characteristics of CTCs
Table 4 : Types of CTCs
Table 5 : Circulating Tumor Cells Features
Table 6 : Metastatic Cascade
Table 7 : EPCAM-Based Assays
Table 8 : Comparison of Different Liquid Biopsy Technologies
Table 9 : Potential Applications of CTC-Based Diagnostics
Table 10 : Clinical Relevance of CTC
Table 11 : CTC Enrichment Methods
Table 12 : Techniques Used for CTC Enrichment
Table 13 : Techniques Used for CTC Analysis
Table 14 : Enumeration Techniques
Table 15 : Functional Assays
Table 16 : Circulating Tumor Cells Technologies
Table 17 : Micro-Count Features: A New Technology
Table 18 : Ranking of Global Vendors of CTC Diagnostics, 2020
Table 19 : Global Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 20 : Global Market for CTC Diagnostics for Breast Cancer, by Region, Through 2026
Table 21 : Global Market for CTC Diagnostics for Colorectal Cancer, by Region, Through 2026
Table 22 : Global Market for CTC Diagnostics for Prostate Cancer, by Region, Through 2026
Table 23 : Global Market for CTC Diagnostics, by Technology, Through 2026
Table 24 : CTC Enrichment Methods
Table 25 : Global Market for CTC Enrichment and Detection, by Region, Through 2026
Table 26 : Global Market for CTC Direct Detection, by Region, Through 2026
Table 27 : Global Market for CTC Analysis, by Region, Through 2026
Table 28 : Global Market for CTC Diagnostics, by Application, Through 2026
Table 29 : Global Market for CTC Diagnostics in Clinical/Liquid Biopsy Applications, by Region, Through 2026
Table 30 : Global Market for CTC Diagnostics in Research Applications, by Region, Through 2026
Table 31 : Global Market for CTC Diagnostics, by Region, Through 2026
Table 32 : North American Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 33 : North American Market for CTC Diagnostics, by Country, Through 2026
Table 34 : Estimated Number of New Cases and Age-Standardized Incidence Rates for Cancers in Canada, by Sex, 2020
Table 35 : European Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 36 : European Market for CTC Diagnostics, by Country, Through 2026
Table 37 : Asia-Pacific Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 38 : Asia-Pacific Market for CTC Diagnostics, by Country, Through 2026
Table 39 : Age-Standardized Cancer Incidence and Mortality Rates in China, by Gender, 2018
Table 40 : Rest of World Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 41 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): R&D Expenditures, 2018-2020
Table 42 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Products Offered
Table 43 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Recent Developments
Table 44 : Biocept, Inc.: R&D Expenditures, 2019 and 2020
Table 45 : Biocept, Inc.: Solutions/Services Offered
Table 46 : Biocept, Inc.: Recent Developments
Table 47 : BioFluidica: Solutions/Services Offered
Table 48 : BioFluidica: Recent Developments
Table 49 : Creatv MicroTech Inc.: Products Offered
Table 50 : Creatv MicroTech Inc: Recent Developments
Table 51 : Fluxion Biosciences, Inc.: Solutions/Services Offered
Table 52 : Fluxion Biosciences, Inc.: Recent Developments
Table 53 : Greiner Bio-One International GmbH: Products Offered
Table 54 : Ikonisys, Inc.: Products Offered
Table 55 : Ikonisys, Inc.: Recent Developments
Table 56 : IVDiagnostics, Inc.: Products/Services Offered
Table 57 : IVDiagnostics, Inc.: Recent Developments
Table 58 : Menarini Silicon Biosystems: Products Offered
Table 59 : Menarini Silicon Biosystems: Recent Developments
Table 60 : Miltenyi Biotec: Products Offered
Table 61 : Precision Medicine Group LLC: Products Offered
Table 62 : Precision Medicine Group LLC: Recent Developments
Table 63 : Qiagen: Products Offered
Table 64 : Qiagen: Recent Developments
Table 65 : Rarecells, Inc.: Products Offered
Table 66 : Rarecells, Inc.: Recent Developments
Table 67 : ScreenCell: Products Offered
Table 68 : ScreenCell: Recent Developments, 2021
Table 69 : STEMCELL Technologies Inc.: Products/Services Offered
Table 70 : STEMCELL Technologies Inc.: Recent Developments
Table 71 : Commonly Used Acronyms in the Market for CTC Diagnostics
List of Figures
Summary Figure : Global Market Shares of Circulating Tumor Cells (CTC) Diagnostics, by Cancer Type, 2020
Figure 1 : Global Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 2 : Global Market for CTC Diagnostics for Breast Cancer, 2019-2026
Figure 3 : Global Market for CTC Diagnostics for Breast Cancer, by Region, 2019-2026
Figure 4 : Global Market for CTC Diagnostics for Colorectal Cancer, 2019-2026
Figure 5 : Global Market for CTC Diagnostics for Colorectal Cancer, by Region, 2019-2026
Figure 6 : Global Market for CTC Diagnostics for Prostate Cancer, 2019-2026
Figure 7 : Global Market for CTC Diagnostics for Prostate Cancer, by Region, 2019-2026
Figure 8 : Global Market Shares of CTC Diagnostics, by Technology, 2020
Figure 9 : Global Market for CTC Enrichment and Detection, 2019-2026
Figure 10 : Global Market for CTC Enrichment and Detection, by Region, 2019-2026
Figure 11 : Global Market for CTC Direct Detection, 2019-2026
Figure 12 : Global Market for CTC Direct Detection, by Region, 2019-2026
Figure 13 : Global Market for CTC Analysis, 2019-2026
Figure 14 : Global Market for CTC Analysis, by Region, 2019-2026
Figure 15 : Global Market Shares of CTC Diagnostics, by Application, 2020
Figure 16 : Global Market for CTC Diagnostics in Clinical/Liquid Biopsy Applications, 2019-2026
Figure 17 : Global Market for CTC Diagnostics in Clinical/Liquid Biopsy Applications, by Region, 2019-2026
Figure 18 : Global Market for CTC Diagnostics in Research Applications, 2019-2026
Figure 19 : Global Market for CTC Diagnostics in Research Applications, by Region, 2019-2026
Figure 20 : Global Market for CTC Diagnostics, by Region, 2019-2026
Figure 21 : Global Market Shares of CTC Diagnostics, by Region, 2020
Figure 22 : North American Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 23 : North American Market Shares of CTC Diagnostics, by Country, 2020
Figure 24 : U.S. Market for CTC Diagnostics, 2019-2026
Figure 25 : Canadian Market for CTC Diagnostics, 2019-2026
Figure 26 : European Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 27 : European Market Shares of CTC Diagnostics, by Country, 2020
Figure 28 : German Market for CTC Diagnostics, 2019-2026
Figure 29 : French Market for CTC Diagnostics, 2019-2026
Figure 30 : U.K. Market for CTC Diagnostics, 2019-2026
Figure 31 : Italian Market for CTC Diagnostics, 2019-2026
Figure 32 : Spanish Market for CTC Diagnostics, 2019-2026
Figure 33 : Rest of European Market for CTC Diagnostics, 2019-2026
Figure 34 : Asia-Pacific Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 35 : Asia-Pacific Market Shares of CTC Diagnostics, by Country, 2020
Figure 36 : Chinese Market for CTC Diagnostics, 2019-2026
Figure 37 : Indian Market for CTC Diagnostics, 2019-2026
Figure 38 : Japanese Market for CTC Diagnostics, 2019-2026
Figure 39 : Australian Market for CTC Diagnostics, 2019-2026
Figure 40 : Rest of Asia-Pacific Market for CTC Diagnostics, 2019-2026
Figure 41 : Rest of World Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 42 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Net Revenue, 2016-2020
Figure 43 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Revenue Share, by Business Segment, 2020
Figure 44 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Revenue Share, by Region, 2020
Figure 45 : Biocept, Inc.: Net Revenue, 2016-2020
Figure 46 : Greiner Bio-One International GmbH: Net Revenue, 2016-2020
Figure 47 : Greiner Bio-One International GmbH: Revenue Share, by Business Segment, 2020
Figure 48 : Greiner Bio-One International GmbH: Revenue Share, by Region, 2020
Figure 49 : Qiagen: Net Revenue, 2016-2020
Figure 50 : Qiagen: Revenue Share, by Business Segment, 2020
Figure 51 : Qiagen: Revenue Share, by Region, 2020